Clinical trial
Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast…
NCT00161291 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00161291 |
|---|---|
| Title | Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer |
| Official title | A Phase II Open Label Trial of Pre-Operative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Letrozole in combination with Bevacizumab |
| Enrollment | 28 |
| Start date | Jun 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 4, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: